From cardiorenal research to emerging cardiovascular–kidney–metabolic frontiers: the knowledge landscape and clinical evidence interpretation in type 2 diabetes-related research (2000–2026)

Background A body of type 2 diabetes mellitus (T2DM)-related cardiovascular and kidney research accumulated before the introduction of the cardiovascular–kidney–metabolic (CKM) health framework. Previous bibliometric studies have focused on traditional cardiorenal topics or recent literature explicitly using CKM-related terminology, leaving the long-term knowledge structure of T2DM-related cardiorenal research and its development toward CKM research insufficiently characterized. This study aimed to map knowledge evolution, examine links between earlier cardiorenal evidence and recent CKM research, and identify emerging research directions. Methods We searched Web of Science Core Collection and Scopus for English-language articles and reviews published from 2000 to 1 June 2026, constructing dataset 1 (D1; T2DM-related cardiorenal research) and dataset 2 (D2; T2DM research using CKM-related terminology). VOSviewer, CiteSpace, and bibliometrix were used to analyze publication trends, collaboration networks, intellectual foundations, thematic structures, and temporal evolution, alongside overlap and thematic links between datasets. Results D1 and D2 included 2,538 and 305 publications, respectively, with 202 shared publications (66.2% of D2). The proportion of annual D1 publications shared with D2 increased from 5.1% in 2023 to 19.9% in 2025. Co-citation and thematic evolution analyses traced an expansion from kidney risk control to multiorgan outcomes. Early research addressed diabetic nephropathy, albuminuria, renin–angiotensin system blockade, and comprehensive risk factor control, alongside cardiovascular outcomes. Research attention subsequently broadened toward cardiorenal outcomes, including chronic kidney disease and heart failure outcomes, as well as multiorgan risk and organ-protective therapies. The D2 analysis identified an interconnected thematic structure encompassing chronic kidney disease, heart failure, obesity, cardiovascular risk, and organ-protective therapies. Keyword bursts for CKM syndrome, glucagon-like peptide-1 receptor agonists, body composition, and gut microbiota remained active at the search cutoff, suggesting growing interest in metabolic risk phenotypes and potential mechanisms. Conclusion The mapped literature showed a broadening of research attention from kidney risk control toward multiorgan outcomes and integrated management, with publication overlap and thematic links between the two retrieved corpora. The dual-dataset design situates emerging CKM frontiers within the historical development of T2DM-related cardiorenal research literature, providing a systematic bibliometric basis for multiorgan risk research and interdisciplinary research agendas from a CKM perspective.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-19
DOI
https://doi.org/10.3389/fendo.2026.2010773
Primary Topic
scientometrics and bibliometrics research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

From cardiorenal research to emerging cardiovascular–kidney–metabolic frontiers: the knowledge landscape and clinical evidence interpretation in type 2 diabetes-related research (2000–2026)

Zhengri Cong, Shaotao Chen, Chongwen Zhong, Zehao Liu et al.
Frontiers in Endocrinology
scientometrics and bibliometrics research
article

From cardiorenal research to emerging cardiovascular–kidney–metabolic frontiers: the knowledge landscape and clinical evidence interpretation in type 2 diabetes-related research (2000–2026)

Zhengri Cong, Shaotao Chen, Chongwen Zhong, Zehao Liu, Jiaxin Liu, Mingjun Liu, Shan Cong
article en

Abstract

Background A body of type 2 diabetes mellitus (T2DM)-related cardiovascular and kidney research accumulated before the introduction of the cardiovascular–kidney–metabolic (CKM) health framework. Previous bibliometric studies have focused on traditional cardiorenal topics or recent literature explicitly using CKM-related terminology, leaving the long-term knowledge structure of T2DM-related cardiorenal research and its development toward CKM research insufficiently characterized. This study aimed to map knowledge evolution, examine links between earlier cardiorenal evidence and recent CKM research, and identify emerging research directions. Methods We searched Web of Science Core Collection and Scopus for English-language articles and reviews published from 2000 to 1 June 2026, constructing dataset 1 (D1; T2DM-related cardiorenal research) and dataset 2 (D2; T2DM research using CKM-related terminology). VOSviewer, CiteSpace, and bibliometrix were used to analyze publication trends, collaboration networks, intellectual foundations, thematic structures, and temporal evolution, alongside overlap and thematic links between datasets. Results D1 and D2 included 2,538 and 305 publications, respectively, with 202 shared publications (66.2% of D2). The proportion of annual D1 publications shared with D2 increased from 5.1% in 2023 to 19.9% in 2025. Co-citation and thematic evolution analyses traced an expansion from kidney risk control to multiorgan outcomes. Early research addressed diabetic nephropathy, albuminuria, renin–angiotensin system blockade, and comprehensive risk factor control, alongside cardiovascular outcomes. Research attention subsequently broadened toward cardiorenal outcomes, including chronic kidney disease and heart failure outcomes, as well as multiorgan risk and organ-protective therapies. The D2 analysis identified an interconnected thematic structure encompassing chronic kidney disease, heart failure, obesity, cardiovascular risk, and organ-protective therapies. Keyword bursts for CKM syndrome, glucagon-like peptide-1 receptor agonists, body composition, and gut microbiota remained active at the search cutoff, suggesting growing interest in metabolic risk phenotypes and potential mechanisms. Conclusion The mapped literature showed a broadening of research attention from kidney risk control toward multiorgan outcomes and integrated management, with publication overlap and thematic links between the two retrieved corpora. The dual-dataset design situates emerging CKM frontiers within the historical development of T2DM-related cardiorenal research literature, providing a systematic bibliometric basis for multiorgan risk research and interdisciplinary research agendas from a CKM perspective.

Frontiers in EndocrinologyVol. 17
Weihai Municipal Hospital (CN), Changchun University of Chinese Medicine (CN)
scientometrics and bibliometrics research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon